|
|
Article: NIH Clinical Center study demonstrates dangerous interaction between St. John' wort and an HIV protease inhibitor.
- Article from:
- M2 Presswire
- Article date:
- February 11, 2000
CopyrightCOPYRIGHT 2000 Normans Media Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-11 February 2000-US DEPT OF HHS: NIH Clinical Center study demonstrates dangerous interaction between St. John' wort and an HIV protease inhibitor (C)1994-2000 M2 COMMUNICATIONS LTD
RDATE:11022000
Researchers at the National Institutes of Health Clinical Center have demonstrated that a widely used herbal product -- St. John's wort -- could significantly compromise the effectiveness of an antiviral drug often prescribed to treat HIV infection.
The findings are detailed in the Feb. 12 issue of "The Lancet". "When St. John's wort and the protease inhibitor indinavir are taken together, the levels of indinavir in the blood drop ...